Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab065
Abstract: Abstract Background The Anemia Studies in chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that daprodustat is noninferior to comparator epoetin alfa or darbepoetin alfa… read more here.
Keywords: dialysis ascend; patients dialysis; ascend trial; baseline characteristics ... See more keywords